“The ACQUITY PREMIER Solution represents our biggest innovation in separation science since UPLC,” said Ian King, Senior Vice President, Global Products, Waters Corporation. “Chromatography has an immeasurable impact on the development of novel therapeutics and treatments for innumerable diseases. The result of decades of separations science know-how along with the combined efforts of our materials scientists, chemists and engineers, ACQUITY PREMIER addresses a long-standing problem that has held back scientific progress long enough. We firmly believe it will redefine the value that separations science brings to scientific achievement.”
MaxPeak High Performance Surface Technology
MaxPeak HPS technology is a hybrid organic/inorganic surface technology that forms a barrier between the sample and the metal surfaces of both the system and column. By mitigating, or eliminating altogether, non-specific adsorption, the ACQUITY PREMIER Solution offers many benefits, among them:
- increased analyte recovery with 10-100X improvement in detectioni sensitivity for low-level phosphorylated and carboxylated analytes reducing the risk of unseen analytes going undetected
- sharper peak shapes and greater peak capacity for more accurate analyte identification and data interpretation
- greater reproducibility for separations prone to adsorptive losses meaning less re-work or troubleshooting, and more confidence in results
- no more system passivation to waste valuable sample material or tie up instrument cycles
- eases the transfer of methods from site-to-site and from company-to-company
- offers UPLC performance for the analysis of both metal-sensitive and non-metal-sensitive analytes making it a truly universal liquid chromatography solution
“This approach solves a real problem with the analysis of some particularly troublesome analytes,” said noted expert and consultant Prof. Ian Wilson, Faculty of Medicine, Dept. of Metabolism, Digestion and Reproduction, Imperial College London. “The improvements in peak shape and signal-to-noise ratio at low concentrations of analytes like phosphorylated drugs and lipids are obvious at a glance and very impressive, and it will make the lives of many analysts much easier.”
The ACQUITY PREMIER System and ACQUITY PREMIER columns are now available worldwide from Waters.
Additional Resources
- Read our white paper: Low Adsorption UPLC Systems Based on MaxPeak High Performance Surfaces: The ACQUITY PREMIER Solution
- Learn more about the ACQUITY PREMIER Solution
- Join our February 10 ACQUITY PREMIER launch event or watch on-demand
- Learn more about the ACQUITY PREMIER Solution for oligonucleotides analysis
- Connect with Waters via LinkedIn, Twitter, and Facebook
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Waters, ACQUITY and MaxPeak are trademarks of Waters Corporation.
|
i Typical results based on Waters lab tests of multiple compounds using both standard UPLC systems and columns compared with ACQUITY PREMIER system and columns featuring MaxPeak HPS. Detection sensitivity may vary depending on the analytes being measured. |
